The Company also advises that last week it relocated its Prince Edward Island Canadian office to Cape Breton as main operations are now based there. Pending final licensing, the Companys Cape Breton based pharmaceutical manufacturing business, Stirling Pharma, is currently quoting on over 15 contract manufacturing proposals that have approached the company. The Company advises that its Managing Director will provide a full update of the Companys business and its advancement and market positioning immediately preceding the Annual Shareholders Meeting on 30 November 2010.
So PB is aware of hotcopper, where is the update
DYOR
STI Price at posting:
0.7¢ Sentiment: Hold Disclosure: Held